CAS 183208-35-7 - Manufacturers, Factory, Suppliers from China

CAS 183208-35-7, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

5-Bromo-7-Azaindole CAS 183208-35-7 Purity >99.0% (GC) Factory High Purity
Read More

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

Related Blog
Reviews

New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

6 October 2021 The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2021 to Benjamin List Max-Planck-Institut für Kohlenforschung, Mülheim an der Ruhr, Germany Da...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021 As the world’s second largest medical market, ...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...

2022.12.17 14:16:16
2022.10.01 19:30:43
2022.08.19 15:46:09
2022.08.18 23:41:32
2022.04.16 15:40:48
2021.10.26 11:14:28

CAS 183208-35-7 - Manufacturers, Factory, Suppliers from China

Related Products

5-Bromo-7-Azaindole CAS 183208-35-7 Purity >99.0% (GC) Factory High Purity

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

DL-10-Camphorsulfonic Acid CAS 5872-08-2 Assay 98.0% to 101.0% High Purity

Guanosine 5'-Monophosphate Disodium Salt Hydrate CAS 5550-12-9 (5'-GMP-Na2) Assay 97.0~102.0% Factory

Thiazole CAS 288-47-1 Purity >99.0% (GC) Manufacturer High Quality

Methyl 3-(Chlorosulfonyl)-2-Thiophenecarboxylate CAS 59337-92-7 Purity >97.0% (HPLC) Tenoxicam Intermediate Factory

5-TAMRA CAS 91809-66-4 Purity >97.0% (HPLC at 254nm)

Guaiacol (2-Methoxyphenol) CAS 90-05-1 Purity >99.0% (GC) High Quality

3-(Trifluoromethyl)pyrazole CAS 20154-03-4 Purity >99.0% (GC) Factory

CAS 13803-74-2 Purity >99.0% (T) Hot Selling

Bismuth Potassium Iodide CAS 41944-01-8 Bismuth (Bi) ≥16.0% Iodide (I-) ≤69.0%

2',5'-Dimethoxyacetophenone CAS 1201-38-3 Purity >99.0% (GC)

1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3 Purity >98.0% (HPLC) Brexpiprazole Intermediate Factory

2-Bromo-5-Chloropyridine CAS 40473-01-6 Assay >98.0% (GC) Factory High Quality

New COVID treatments offer hope

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

Paxlovid: what we know about Pfizer's Covid-19 pill

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Xi presents award to top scientists

2022.12.17 14:16:16

2022.10.01 19:30:43

2022.08.19 15:46:09

2022.08.18 23:41:32

2022.04.16 15:40:48

2021.10.26 11:14:28

related search